Filed: 2/9/2024ACC: 0000895345-24-000038
📋 What this filing means
ALERCE INVESTMENT MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $75.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$75.15M
Total AUM (reported)
36.55M
Total Shares
Allocation by class
COM$57.01M75.9%
CL A$15.61M20.8%
COM NEW$2.53M3.4%
Portfolio Concentration
Top 3$69.33M92.2%
4–10$5.83M7.8%
Top 3 weight
92.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 36.55M
Sole
Full voting authority
36.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ANNEXON INC
SOLEShares7.41M
TypeSH
Market value$33.62M
44.74%
Sole
7.41M
Shared
0.00
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares16.21M
TypeSH
Market value$20.09M
26.74%
Sole
16.21M
Shared
0.00
None
0.00
AMERICAN WELL CORP
SOLEShares10.48M
TypeSH
Market value$15.61M
20.77%
Sole
10.48M
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares1.63M
TypeSH
Market value$3.29M
4.38%
Sole
1.63M
Shared
0.00
None
0.00
AILERON THERAPEUTICS INC
SOLEShares830.47K
TypeSH
Market value$2.53M
3.37%
Sole
830.47K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANNEXON INCSOLE | COM | 7.41M | SH | $33.62M 44.74% | 7.41M | 0.00 | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 16.21M | SH | $20.09M 26.74% | 16.21M | 0.00 | 0.00 |
AMERICAN WELL CORPSOLE | CL A | 10.48M | SH | $15.61M 20.77% | 10.48M | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 1.63M | SH | $3.29M 4.38% | 1.63M | 0.00 | 0.00 |
AILERON THERAPEUTICS INCSOLE | COM NEW | 830.47K | SH | $2.53M 3.37% | 830.47K | 0.00 | 0.00 |